Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children’s Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation – JLABS in South San Francisco.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 1100 Island Dr,
- in****@****nes.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- meissavaccines.com
- Keywords
- Vaccines, Infectious Diseases, Respiratory syncytial virus, Rhinovirus, Synthetic Biology, Parainfluenza, human metapneumovirus, Reverse Genetics.
- HQ
- Downtown Redwood City, California
Meissa Vaccines Questions
Meissa Vaccines's website is meissavaccines.com
Meissa Vaccines's LinkedIn profile is https://www.linkedin.com/company/meissa-vaccines
Meissa Vaccines has
3 employees.
View email and phone details for 3
employees at Meissa Vaccines.
Meissa Vaccines's industry is
Biotechnology Research
Meissa Vaccines's top competitors are
Caribou Biosciences,
Thinkcyte,
Blue Lake Biotechnology,
Vbi Vaccines Inc.,
Rrpv | Rapid Response Partnership Vehicle,
Eazebio,
Antheia, Inc.,
Altravax, Inc.,
Vaxart, Inc.,
Remegen Biosciences.
Meissa Vaccines's support email address is info@meissavaccines.com
Meissa Vaccines's categories are Biotechnology Research
Meissa Vaccines's founding year is 2014
